Reproductive health

Showing 12 posts of 12 posts found.

Uterine fibroids and the cost of silence

October 9, 2025
Medical Communications, Research and Development Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. Itโ€™s completely natural โ€“ …

Endometriosis - Woman holding stomach in pain

The Problem of Endometriosis in the UK

July 7, 2025
Research and Development NHS, Obstetrics & Gynaecology, Pain, Reproductive health, Theramex, endometriosis, gynaecology

When did we decide it was an acceptable condition of womanhood in the UK to live with chronic pain?

Ferring strengthens evidence for flexible dosing of follitropin delta in IVF

July 3, 2025
Research and Development Ferring Pharmaceuticals, IVF, Reproductive health, clinical trial, fertility treatment, in vitro fertilisation, ovarian hyperstimulation syndrome, pregnancy, reproductive health, reproductive medicine

Ferring Pharmaceuticals has reported that a conventional 15ยตg/day starting dose of follitropin delta (Rekovelle) provides comparable efficacy and safety to …

New hormonal treatment launched to help prevent miscarriage in early pregnancy

April 4, 2025
Research and Development Besins Healthcare, Reproductive health, hormonal therapy, miscarriage, pregnancy

A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that …

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024
Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated womenโ€™s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …

First oral treatment for hormone-sensitive prostate cancer recommended by NICE

August 15, 2024
Research and Development Accord healthcare, Oncology, Reproductive health, hormone-sensitive, prostate cancer

Today, Accord Healthcare has announced that the National Institute for Health and Care excellence (NICE) have recommended the first oral …

US FDA expandsย Jemperliย (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit

August 5, 2024
Research and Development GSK, Oncology, Reproductive health, endometrial cancer

PHILADELPHIA–GSK plc today announced the US Food and Drug Administration (FDA) has approvedย Jemperliย (dostarlimab-gxly) in combination with carboplatin and paclitaxel (chemotherapy) …

Oxolife shares data from phase 2 trial for infertility drug

July 8, 2024
Research and Development Oxolife, Reproductive health, clinical trial, infertility

Oxolife has announced positive phase 2 clinical data on its fertility pill OXO-001 at the European Society of Human Reproduction …

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024
Research and Development GSK, Reproductive health, clinical trial, gonorrhoea, sexual health

GSK has announced positive results from its phase 3 EAGLE-1 trial for gepotidacin, a potential first-in-class oral antibiotic for the …

An overview of womenโ€™s health in 2024

April 9, 2024
Reproductive health, abortion, fertility, reproductive health, women's health

Betsy Goodfellow fromย Pharmafocusย considers the current landscape of womenโ€™s health, covering recent debates and ongoing issues within the reproductive health sphere …

J&Jโ€™s nipocalimab gains breakthrough therapy designation from FDA for HDFN treatment

February 12, 2024
Medical Communications Breakthrough Therapy Designation, FDA, HDFN, J&J, Reproductive health

Johnson & Johnson (J&J) has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) …

The Gateway to Local Adoption Series

Latest content